Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Reviews

Epidemiology of alcoholic liver disease in Korea

Jae Young Jang, Dong Joon Kim

Clin Mol Hepatol. 2018;24(2):93-99. Published online March 16, 2018

Web of Science 21 Crossref 18

DOI: https://doi.org/10.3350/cmh.2017.0079

Microbiota, a key player in alcoholic liver disease

Anne-Marie Cassard, Dragos Ciocan

Clin Mol Hepatol. 2018;24(2):100-107. Published online December 22, 2017

Web of Science 59 Crossref 60

DOI: https://doi.org/10.3350/cmh.2017.0067

Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend

Grace Lai-Hung Wong

Clin Mol Hepatol. 2018;24(2):108-113. Published online January 22, 2018

Web of Science 37 Crossref 39

DOI: https://doi.org/10.3350/cmh.2017.0068

Strategic application of radiotherapy for hepatocellular carcinoma

Seo Hee Choi, Jinsil Seong

Clin Mol Hepatol. 2018;24(2):114-134. Published online February 14, 2018

Web of Science 36 Crossref 41

DOI: https://doi.org/10.3350/cmh.2017.0073

Editorial

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion

Jin Wook Chung

Clin Mol Hepatol. 2018;24(2):135-136. Published online February 22, 2018

DOI: https://doi.org/10.3350/cmh.2018.1001

Special Article

Journal metrics of Clinical and Molecular Hepatology based on the Web of Science Core Collection

Sun Huh

Clin Mol Hepatol. 2018;24(2):137-143. Published online June 22, 2018

Web of Science 6 Crossref 5

DOI: https://doi.org/10.3350/cmh.2018.0018

Original Articles

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion

Danbi Lee, Han Chu Lee, Jihyun An, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2018;24(2):144-150. Published online January 16, 2018

Web of Science 12 Crossref 11

DOI: https://doi.org/10.3350/cmh.2017.0041

Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals

Alessio Strazzulla, Giuseppe Coppolino, Giorgio Settimo Barreca, Innocenza Gentile, Laura Rivoli, Maria Concetta Postorino, Maria Mazzitelli, Giuseppe Greco, Chiara Costa, Vincenzo Pisani, Nadia Marascio, Mariadelina Simeoni, Alfredo Focà, Giorgio Fuiano, Daniela Foti, Elio Gulletta, Carlo Torti

Clin Mol Hepatol. 2018;24(2):151-162. Published online April 24, 2018

Web of Science 13 Crossref 12

DOI: https://doi.org/10.3350/cmh.2017.0059

Case Report

Living-donor liver transplantation for giant hepatic hemangioma with diffuse hemangiomatosis in an adult: a case report

Ju Hyun Lee, Chang Jin Yoon, Young Hoon Kim, Ho-Seong Han, Jai Young Cho, Haeryoung Kim, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong

Clin Mol Hepatol. 2018;24(2):163-168. Published online July 19, 2017

Web of Science 14 Crossref 14

DOI: https://doi.org/10.3350/cmh.2017.0002

Viewed By 5374	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5333	MAFLD: How is it different from NAFLD?
Viewed By 5218	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3900	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3860	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Previous issues